About
iSTAR Medical is a clinical-stage medical technology company based in Wavre, Belgium, founded in 2011. The company focuses on developing innovative, minimally invasive ophthalmic implants for the treatment of glaucoma, a leading cause of adult blindness. Their core innovation is the proprietary STAR® material, which enhances bio-integration and fluid drainage, improving patient outcomes. The flagship product, MINIject®, is a micro-invasive glaucoma surgery device designed to safely and effectively reduce intraocular pressure in patients with primary open-angle glaucoma. Approved for use in Europe, MINIject® is recognized as a leading solution in the growing global market for minimally invasive glaucoma surgery. iSTAR Medical also developed STARflo, a first-generation device that has received positive feedback from clinical trials. Operating primarily in Europe and the Asia Pacific region, iSTAR Medical is privately owned and led by CEO Michel Vanbrabant. The company aims to improve patient outcomes through advanced medical technology and targets ophthalmologists and healthcare providers specializing in glaucoma treatment.
Technologies
Keywords
Company Information
-
Employees 47
-
Founded 2010
-
Annual Revenue $8000000
-
Total Funding $60957559
Location
6 Avenue Sabin, Wavre, Walloon Region, Belgium, 1300